# A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults

> **NCT03105986** · PHASE1 · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-64041575
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT03105986
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2017-06-16
- **Final completion:** 2017-06-16
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03105986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03105986, "A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03105986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*